ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO448

Significance of Cardio-Ankle Vascular Index in the Long-Term Renal Prognosis for Patients with Non-Diabetic CKD

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 301 CKD: Risk Factors for Incidence and Progression

Authors

  • Shimizu, Akihiro, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Okonogi, Hideo, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Kawamura, Tetsuya, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Yokote, Shinya, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Suyama, Masahiro, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Matsumoto, Kei, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Koike, Kentaro, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Tsuboi, Nobuo, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Miyazaki, Yoichi, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Ikeda, Masato, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Ogura, Makoto, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
  • Yokoo, Takashi, Division of nephrology and hypertension, The Jikei university school of medicine, Tokyo, Japan
Background

Cardio-ankle vascular index (CAVI) is a non-invasive index of arterial stiffness and, theoretically, independent of blood pressure at the time of measurement. Although the role of CAVI as a predictor of cardiovascular events has been reported, few studies have considered the renal prognosis. The present retrospective cohort study was undertaken to investigate the association between CAVI and the long-term renal prognosis in patients with non-diabetic chronic kidney disease (NDCKD).

Methods

We included 44 NDCKD patients (CKD stages 1, 2, 3 and 4, and follow-up period ≥2 years), who were diagnosed by first time renal biopsy (RBx). Renal outcome was defined as reaching 30% decline in eGFR from baseline. We analyzed the association between CAVI and outcome, and risk factors affecting the incidence of outcome, by Cox proportional hazard model, receiver-operating characteristic (ROC) analysis, and Kaplan–Meier analysis.

Results

As a result, a median follow-up time was 86 months (range, 27–101 months), and 15 patients reached outcome. Baseline CAVI, eGFR, hypertension and uric acid were significantly associated with outcome by univariate Cox analysis (p<0.05). By ROC analysis, the areas under the curve for diagnosis of the future outcome by baseline CAVI was 0.838 (p=0.0007), and CAVI cut-off value was calculated as 7.50 (Sensitivity 93%, Specificity 62%). Then CAVI≥7.5 (HCAVI) and eGFR were independently associated with outcome by multivariate Cox analysis, (Hazard ratio (HR) 7.3, 95% confidence interval (CI) 1.2-141, p<0.05, and HR 0.97, 95%CI 0.94-0.99, p<0.05, respectively). Furthermore, Kaplan-Meier analysis showed that outcome-free survival was significantly lower in HCAVI group compared with CAVI<7.5 group (Log-rank test, p=0.0017).

Conclusion

These results indicated that CAVI at the time of RBx was independently associated with long-term renal prognosis in NDCKD patients.